Free Trial
NASDAQ:ONC

BeOne Medicines (ONC) Stock Price, News & Analysis

BeOne Medicines logo
$245.49 +1.17 (+0.48%)
As of 07/3/2025 01:00 PM Eastern

About BeOne Medicines Stock (NASDAQ:ONC)

Key Stats

Today's Range
$243.71
$247.52
50-Day Range
$219.95
$276.53
52-Week Range
$142.00
$287.88
Volume
172,489 shs
Average Volume
360,050 shs
Market Capitalization
$26.91 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$320.67
Consensus Rating
Buy

Company Overview

BeOne Medicines Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
60th Percentile Overall Score

ONC MarketRank™: 

BeOne Medicines scored higher than 60% of companies evaluated by MarketBeat, and ranked 404th out of 922 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    BeOne Medicines has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 6 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    BeOne Medicines has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about BeOne Medicines' stock forecast and price target.
  • Earnings Growth

    Earnings for BeOne Medicines are expected to grow in the coming year, from ($5.82) to $0.71 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of BeOne Medicines is -65.99, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of BeOne Medicines is -65.99, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    BeOne Medicines has a P/B Ratio of 7.20. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for ONC.
  • Dividend Yield

    BeOne Medicines does not currently pay a dividend.

  • Dividend Growth

    BeOne Medicines does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for ONC.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for BeOne Medicines this week, compared to 7 articles on an average week.
  • Search Interest

    14 people have searched for ONC on MarketBeat in the last 30 days. This is an increase of 367% compared to the previous 30 days.
  • MarketBeat Follows

    3 people have added BeOne Medicines to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, BeOne Medicines insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $37,245,810.00 in company stock.

  • Percentage Held by Insiders

    Only 6.62% of the stock of BeOne Medicines is held by insiders.

  • Percentage Held by Institutions

    48.55% of the stock of BeOne Medicines is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about BeOne Medicines' insider trading history.
Receive ONC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BeOne Medicines and its competitors with MarketBeat's FREE daily newsletter.

ONC Stock News Headlines

July 4th: 59% dividend from Bitcoin (No Crypto Needed)
I've got something exciting for you this July 4th holiday... How about a 59.07% dividend from Bitcoin? Yes, you read that right. And no, you don't need to buy any cryptocurrency or trade options... Here's the deal: Our July 4th special includes a FREE report on what I call the "Bitcoin Income Vault."
See More Headlines

ONC Stock Analysis - Frequently Asked Questions

BeOne Medicines' stock was trading at $223.50 at the beginning of 2025. Since then, ONC stock has increased by 9.8% and is now trading at $245.49.

BeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC) issued its quarterly earnings results on Wednesday, May, 7th. The company reported $1.22 earnings per share for the quarter, beating the consensus estimate of ($0.71) by $1.93. The firm earned $1.12 billion during the quarter, compared to the consensus estimate of $1.12 billion. BeOne Medicines had a negative trailing twelve-month return on equity of 7.55% and a negative net margin of 9.40%.

Shares of ONC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
5/07/2025
Today
7/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ONC
Previous Symbol
NASDAQ:ONC
Web
N/A
Fax
N/A
Employees
11,000
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$320.67
High Stock Price Target
$350.00
Low Stock Price Target
$259.00
Potential Upside/Downside
+30.6%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
6 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$644.79 million
Pretax Margin
-6.43%

Debt

Sales & Book Value

Annual Sales
$3.81 billion
Price / Cash Flow
N/A
Book Value
$34.10 per share
Price / Book
7.20

Miscellaneous

Free Float
102,344,000
Market Cap
$26.91 billion
Optionable
N/A
Beta
0.28
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

This page (NASDAQ:ONC) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners